Oral Cancer Treatment in India

Expert oral cancer treatment in India — surgical resection, free flap reconstruction, radiation therapy, and immunotherapy. Specialist head and neck oncologists. Costs 70% lower.

Estimated cost: $4,000 – $9,000 · Average stay: 7–14 days

Oral cavity cancer — cancer affecting the lips, tongue, gums, floor of mouth, cheek lining, and hard palate — accounts for approximately 380,000 new cases globally each year. India carries an especially high burden of oral cancer due to widespread betel nut chewing, tobacco use, and alcohol consumption. This has made India home to some of the world's most experienced head and neck surgical oncologists.

Early-stage oral cancer (stage I–II) has a 5-year survival of 70–85% with surgery alone. Advanced disease (stage III–IV) requires multimodal treatment — surgery, radiation, and often chemotherapy — with 5-year survival of 30–60%. The functional outcomes — preservation of speech, swallowing, and appearance — are just as critical as cancer control, making the choice of a specialized head and neck center with experienced reconstructive surgeons paramount.

India's head and neck oncology programs are world-class by any measure. Tata Memorial Hospital in Mumbai treats among the highest volumes of head and neck cancer patients in the world. Surgeons experienced in free flap microvascular reconstruction rebuild the oral cavity and jaw with the patient's own tissue, restoring form and function after extensive resections.

Gaf Healthcare connects oral cancer patients with India's leading head and neck oncology centers, ensuring they receive expert surgical resection, expert reconstruction, and evidence-based adjuvant treatment.

Types and Causes of Oral Cancer

Oral squamous cell carcinoma (OSCC) accounts for over 90% of oral cavity cancers. It arises from the squamous epithelium lining the mouth. The most common sites are the tongue (lateral border), floor of mouth, and buccal mucosa (cheek lining).

Major risk factors: tobacco (smoked and smokeless), areca nut/betel quid, heavy alcohol consumption, and HPV infection (particularly HPV-16 for oropharyngeal cancer). The combination of tobacco, betel, and alcohol dramatically multiplies risk.

Clinical staging (AJCC 8th edition):

  • Stage I: Tumor ≤2 cm, no nodal involvement. Surgery alone is curative in most patients.
  • Stage II: Tumor 2–4 cm, no nodal involvement. Surgery preferred; some benefit from adjuvant radiation.
  • Stage III: Tumor >4 cm or single ipsilateral lymph node ≤3 cm. Surgery + adjuvant radiation ± chemotherapy.
  • Stage IV: Extensive local invasion, multiple lymph nodes, or distant metastasis. Multimodal treatment required.

Correct staging requires physical examination, contrast CT of neck, chest CT, and MRI for tongue and floor of mouth assessment.

Who Is a Candidate for Oral Cancer Treatment?

All patients with confirmed oral cavity squamous cell carcinoma require oncologic treatment. Surgery is the primary treatment for oral cavity cancers in most clinical stages.

Surgical candidates: patients with resectable stage I–IVA oral cavity cancer who are medically fit. Surgical resection with adequate margins (≥5 mm) is the standard. Neck dissection (ipsilateral or bilateral) is performed when lymph node involvement is confirmed or suspected.

Free flap reconstruction candidates: patients requiring resection of large portions of the tongue, floor of mouth, mandible, or cheek benefit from immediate microvascular free flap reconstruction. The radial forearm free flap is most commonly used for tongue and floor of mouth. The fibula free flap is used for mandibular reconstruction. Reconstruction is performed by a plastic/reconstructive surgeon during the same operative session.

Adjuvant radiation candidates: all patients with stage III–IVA disease, positive margins, lymph node involvement with extracapsular extension, or multiple positive lymph nodes. Adjuvant cisplatin chemotherapy is added when extracapsular extension or positive surgical margins are present.

Oral Cancer Surgery and Reconstruction

Wide local excision of the primary tumor is performed with a minimum 1 cm mucosal margin and adequate deep margin to include the underlying muscle. For tongue cancers, hemiglossectomy (removal of half the tongue) or total glossectomy is performed depending on tumor extent.

Mandibulectomy — removal of a portion of the jaw bone — is performed when tumor invades the mandible. Marginal mandibulectomy (removing the outer cortex only) is preferred when bone involvement is not extensive; segmental mandibulectomy (removing a full segment of the mandible) is required for extensive invasion and mandated for posterior involvement.

Neck dissection: selective neck dissection of levels I–III is performed prophylactically even for clinical N0 (node-negative) stage II–III tumors due to high occult nodal metastasis rates. Modified radical neck dissection is performed for clinical lymph node involvement.

Microvascular free flap reconstruction: the defect created by tumor removal is reconstructed using tissue harvested from a distant site (radial forearm, fibula, anterolateral thigh, or rectus abdominis). The flap is transferred to the neck with microsurgical anastomosis of the feeding vessels under magnification. This is a major, 6–10 hour combined procedure requiring experienced teams.

Procedure Steps

  1. Biopsy with histopathology confirming squamous cell carcinoma; depth of invasion measurement.
  2. Staging: clinical exam, contrast CT neck + chest; MRI for tongue and floor of mouth; PET-CT for advanced disease.
  3. Multidisciplinary head and neck tumor board: surgeon + radiation oncologist + medical oncologist.
  4. Wide local excision with mandibulectomy if needed and concurrent neck dissection.
  5. Microvascular free flap reconstruction: radial forearm flap (tongue/soft tissue) or fibula flap (mandible).
  6. Post-operative pathology: margin status, lymph node count, extracapsular extension.
  7. Adjuvant radiation (55–66 Gy) starting 4–6 weeks after surgery, with concurrent cisplatin for high-risk features.
  8. Speech and swallowing rehabilitation: multidisciplinary speech language pathology throughout treatment.

Oral Cancer Treatment Approaches

Surgical Resection + Neck Dissection

Wide local excision of the oral tumor with clear margins, combined with selective or modified radical neck dissection to address cervical lymph node disease. The cornerstone of oral cavity cancer management for resectable disease.

Cost: $4,500 – $9,000

Microvascular Free Flap Reconstruction

Immediate reconstruction of large surgical defects using tissue transplanted from the forearm, leg, or thigh with microsurgical vascular anastomosis. Restores tongue mobility, speech, swallowing, and jaw contour. Available at dedicated head and neck centers.

Cost: $5,000 – $10,000 (combined with resection)

Adjuvant IMRT Radiation

Intensity-modulated radiation therapy (IMRT) to the primary site and regional lymph nodes after surgery. Reduces local recurrence risk by 40–50% in intermediate and high-risk disease. 6-week daily treatment course. Salivary gland sparing IMRT minimizes xerostomia.

Cost: $4,000 – $8,000 (full course)

Pembrolizumab + Chemotherapy (Advanced/Recurrent)

PD-1 inhibitor immunotherapy combined with platinum + 5-FU chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma. First-line treatment for PD-L1 expressing tumors (KEYNOTE-048).

Cost: $2,000 – $4,500 per cycle

Cost Comparison Worldwide

Country — Range — Savings

--- — --- — ---

India — $4,000 – $9,000 — Save 70–80%

UAE — $8,000 – $15,000 — Save 55–65%

USA / UK — $25,000 – $80,000+ — Baseline

India's head and neck oncology centers offer world-class surgical resection and microvascular free flap reconstruction — procedures that cost $50,000–$100,000 in the USA — for $8,000–$18,000 total including surgery, reconstruction, and complete adjuvant radiation. India's high disease volume has created unparalleled surgical expertise in this challenging field.

Recovery & Follow-up

Hospital stay after oral cancer surgery with free flap reconstruction is 10–14 days. A tracheostomy (temporary breathing tube) and nasogastric feeding tube are placed during major resections and removed as swallowing and airway safety are confirmed over 1–3 weeks. Speech and swallowing therapy begins immediately and continues for 3–6 months. Adjuvant radiation starts 4–6 weeks after surgery, running for 6 weeks. Xerostomia (dry mouth) from radiation is the most persistent long-term side effect.

Recovery Tips

  • Work closely with the speech language pathologist from day 1 — early swallowing therapy prevents long-term dysfunction.
  • Use prescribed salivary substitutes and sip water frequently during radiation to manage dry mouth.
  • Maintain excellent oral hygiene throughout radiation — dental fluoride trays reduce radiation-induced decay.
  • Avoid tobacco and alcohol completely — these dramatically increase recurrence risk and impair healing.
  • Attend all oncology follow-up appointments — the first 2 years after treatment carry the highest recurrence risk.

Risks & Complications

Risks of oral cancer surgery include wound infection, fistula formation, free flap failure (3–5%), tracheostomy-related complications, and temporary or permanent swallowing difficulties. Neck dissection risks include shoulder dysfunction, numbness, and rare nerve injury. Radiation risks include xerostomia, mucositis, osteoradionecrosis of the jaw (risk minimized with dental prophylaxis), and taste changes.

Why GAF Healthcare

Gaf Healthcare connects oral cancer patients with India's highest-volume head and neck oncology centers — institutions with dedicated microvascular reconstruction teams and integrated speech and swallowing rehabilitation programs. We coordinate the complex multidisciplinary care that oral cancer demands, ensuring patients receive every component of treatment at an expert center.

Frequently Asked Questions

What is the survival rate for oral cancer?

Five-year survival by stage: Stage I — 75–85%, Stage II — 65–75%, Stage III — 40–55%, Stage IV — 25–40%. Outcomes significantly improve with early detection. Regular self-examination and annual dental check-ups remain the most effective early detection tools.

Will I be able to speak and eat normally after oral cancer surgery?

Speech and swallowing outcomes depend on the extent of resection. Small tongue excisions preserve nearly normal function. Hemiglossectomy with free flap reconstruction achieves good functional outcomes with rehabilitation. Total glossectomy causes significant long-term speech and swallowing challenges, but a speech pathology program significantly improves outcomes.

What is a free flap and why is it needed?

A free flap is living tissue (skin, muscle, and fat) transplanted from another body site to reconstruct the defect left after tumor removal. It is needed when the resection is too large to close primarily. The tissue is connected by microsurgical suturing of arteries and veins under magnification. A successful free flap takes 5–7 days to fully incorporate.

How long does oral cancer radiation treatment last?

Adjuvant IMRT for oral cancer is delivered over 6 weeks — 30 daily fractions at 2 Gy per fraction (total 60 Gy). Concurrent weekly cisplatin chemotherapy is added for high-risk features. Treatment is given Monday–Friday, with weekends off. Most patients receive this as an outpatient.

What are the early warning signs of oral cancer?

Warning signs include: a persistent mouth sore that does not heal within 2 weeks; a white or red patch in the mouth (leukoplakia or erythroplakia); unexplained mouth pain; difficulty swallowing or chewing; a lump or thickening in the cheek; or unexplained neck swelling. Any of these warrant urgent evaluation.

  • Home
  • All Treatments
  • Our Doctors
  • Get a Free Quote
  • Related Treatments
  • Blood Cancer Treatment
  • Liver Transplant
  • Total Knee Replacement
  • IVF Treatment
  • Heart Bypass Surgery